Analyse court terme - BIOMERIEUX : Le MACD a croisé en hausse.
Le niveau d'invalidation a été à peine enfoncé, nous attendons un peu avant de prendre en compte ce signal.Arguments :
- Le support majeur a été enfoncé, mais il est réintégré. Les prix peuvent rebondir.
- Le MACD a croisé en hausse.
- La moyenne mobile sert de support.
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.